IRIS BIOTECHNOLOGIES INC
CIK 0001396238
Revenue (TTM)
—
Q3 Nov 2016
Net Income (TTM)
−$1.08M
+1.6% YoY
Q3 Nov 2016
EPS Diluted (TTM)
—
Q3 Nov 2016
Gross Margin
—
Q3 Nov 2016
Operating Margin
—
Q3 Nov 2016
Net Margin
—
Q3 Nov 2016
Free Cash Flow (TTM)
−$465.17K
Q3 Nov 2016
Cash
$9.95K
Q3 Nov 2016
Total Debt
—
Q3 Nov 2016
Shares Outstanding
21.37M sh
Q3 Nov 2016
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.